Azelaic Acid: Mechanisms of Action and Clinical Applications
Xiaoyue Feng,Jianli Shang,Zhengping Gu,Junhua Gong,Yong Chen,Youting Liu
DOI: https://doi.org/10.2147/ccid.s485237
2024-10-23
Clinical Cosmetic and Investigational Dermatology
Abstract:Xiaoyue Feng, 1, &ast Jianli Shang, 1, &ast Zhengping Gu, 1 Junhua Gong, 1 Yong Chen, 1, 2 Youting Liu 1, 2 1 R&D Department, Beijing UPROVEN Medical Technology Co., Ltd., Beijing, Daxing, People's Republic of China; 2 Beijing UPROVEN Institute of Dermatology, Beijing, Daxing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Youting Liu, R&D Department, Beijing UPROVEN Medical Technology Co., Ltd., Yard 5, Tianhua Avenue, Beijing, Daxing, 102699, People's Republic of China, Tel +86 18510256963, Email AZA is a non-phenolic, saturated dicarboxylic acid with nine carbon atoms, naturally produced by the yeast Malassezia. It has diverse physiological activities, including antibacterial, anti-keratinizing, antimelanogenic, antioxidant and anti-inflammatory effects. AZA is widely used in dermatology and is FDA-approved for treating papulopustular rosacea. It also shows significant efficacy in acne vulgaris and melasma. This review summarizes the mechanisms of action and clinical applications of AZA, aiming to provide theoretical support for its clinical and cosmetic use and to facilitate further research. Keywords: azelaic acid, mechanism, rosacea, acne, melasma, safety Azelaic acid (AZA), also known as azalea acid, is a beautiful mistake. Upon investigation, it was found that it has little to do with azaleas, as the similarity in their English names led to its early translation as azalea acid. AZA is widely present in nature, found in grains such as rye, wheat, and barley. 1 In the human body, it exists in small amounts in the urine of healthy individuals as a physiological component, synthesized from fatty acids via ω-oxidation. 2 Additionally, on the human skin surface, Pityrosporum ovale synthesizes and secretes AZA. 3 The discovery of AZA in dermatology dates back to the 1970s, significant depigmentation was found in the lesions of pityriasis versicolor by a dermatologist in Rome. Further research revealed that the yeast Malassezia furfur, a normal skin commensal, could degrade unsaturated fatty acids into C8-C12 dicarboxylic acids, including AZA, which inhibit melanocytes. 4 AZA was first applied in combination with surgical treatment for malignant melanoma patients in 1980, achieving good results. 5 Subsequently, extensive research on AZA revealed its remarkable efficacy not only in inhibiting melanogenesis but also in exhibiting multiple physiological activities such as antibacterial, anti-keratinization, antimelanogenic, antioxidant and anti-inflammatory effects. It is extensively used in the treatment of various conditions, including rosacea, acne vulgaris, and melasma. In recent years, its popularity in cosmetics has been steadily increasing, indicating a broad application prospect. Therefore, we systematically review the various mechanisms of action and clinical applications of AZA to provide theoretical support for its use in clinical and cosmetic fields and to lay the foundation for further research. AZA is a straight-chain saturated dicarboxylic acid with the molecular formula C 9 H 16 O 4 and a molecular weight of 188.22. Due to its two carboxyl groups, it dissociates as a weak acid in aqueous solutions, with two pKa values, pKa1 at 4.5 and pKa2 at 5.3. The absorption of AZA strongly depends on the pH value and degree of dissociation in the topical formulation. Unlike other substances, increased dissociation enhances the absorption rate of AZA in the skin. 6 This is likely because higher dissociation improves the solubility of AZA in the formulation, thereby increasing the total skin permeation. We systematically elucidated and refined the potential mechanisms underlying AZA's effects on antibacterial activity, keratinization inhibition, melanogenesis suppression, antioxidant and anti-inflammatory responses through a comprehensive analysis of AZA's structure and properties, as illustrated in Figure 1. Figure 1 Mechanism of Action of AZA. This figure illustrates the mechanisms of action of AZA using different line colors: pink for the antibacterial mechanism, yellow for the anti-keratinization mechanism, blue for the antimelanogenic mechanism, and green for the antioxidant and anti-inflammatory mechanisms. AZA, Azelaic acid. AZA exhibits bacteriostatic activity against bacteria such as Propionibacterium acnes, Staphylococcus epidermidis, Staphylococcus aureus , and Pseudomonas aeruginosa , as demonstrated by in vitro studies. Its bacteriostatic efficacy is concentration and pH-dependent, with more pronounced effects at low pH and high concentrations. 7,8 Unlike antibioti -Abstract Truncated-
dermatology